{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:08:34Z","timestamp":1793423314021,"version":"4.5.0"},"reference-count":100,"publisher":"Massachusetts Medical Society","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,11,2]]},"DOI":"10.1056\/nejmra2216474","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T17:01:25Z","timestamp":1698858085000},"page":"1693-1707","source":"Crossref","is-referenced-by-count":355,"title":["Cystic Fibrosis"],"prefix":"10.1056","volume":"389","author":[{"given":"Hartmut","family":"Grasemann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-6592","authenticated-orcid":false,"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.10"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1300109"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.10.008"},{"key":"e_1_3_3_5_2","unstructured":"The Clinical and Functional TRanslation of CFTR (CFTR2). US CF Foundation Johns Hopkins University The Hospital for Sick Children 2011 (https:\/\/cftr2.org)."},{"key":"e_1_3_3_6_2","unstructured":"Cystic Fibrosis Foundation patient registry 2021 annual data report. Bethesda MD: Cystic Fibrosis Foundation 2022 (https:\/\/www.cff.org\/sites\/default\/files\/2021-11\/Patient-Registry-Annual-Data-Report.pdf)."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25285"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102239"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121868"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2391-y"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-016-2562-z"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2018.05.006"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00422.2015"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature11130"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.122695"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167957"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.01.007"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105185"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908639"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.04.005"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.01.004"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau7531"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2023.01.016"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.046"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2019-0484"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2022.07.001"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.26279"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.32"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2015.01.001"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.09.064"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(11)60014-3"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031437"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30337-6"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909825"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1308349"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01113-2019"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409547"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709847"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709846"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1712335"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807120"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2100665"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00454-9"},{"key":"e_1_3_3_44_2","unstructured":"List of CFTR gene mutations that are responsive to Trikafta (elexacaftor\/tezacaftor\/ivacaftor). Cystic Fibrosis Foundation (https:\/\/www.cff.org\/sites\/default\/files\/2022-02\/Trikafta-Approved-Mutations.pdf)."},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.04.019"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.04.013"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70026-2"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202301-0084OC"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200812-1845PP"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.4187\/aarc0443"},{"key":"e_1_3_3_51_2","first-page":"CD001127","article-title":"Dornase alfa for cystic fibrosis.","volume":"3","author":"Yang C","year":"2021","unstructured":"Yang C, Montgomery M. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev 2021;3:CD001127-CD001127.33735508","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043900"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00546-4"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30187-0"},{"key":"e_1_3_3_55_2","unstructured":"Highlights of prescribing information: Kalydeco. Boston: Vertex Pharmaceuticals Incorporated 2017 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/203188s022l_207925s003lbl.pdf)."},{"key":"e_1_3_3_56_2","unstructured":"Highlights of prescribing information: Orkambi. Boston: Vertex Pharmaceuticals Incorporated 2023 (https:\/\/pi.vrtx.com\/files\/uspi_lumacaftor_ivacaftor.pdf)."},{"key":"e_1_3_3_57_2","unstructured":"Highlights of prescribing information: Symdeko. Boston: Vertex Pharmaceuticals Incorporated 2018 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210491lbl.pdf)."},{"key":"e_1_3_3_58_2","unstructured":"Highlights of prescribing information: Trikafta. Boston: Vertex Pharmaceuticals Incorporated 2019 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/212273s000lbl.pdf)."},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piac052"},{"key":"e_1_3_3_60_2","first-page":"CD010004","article-title":"Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.","volume":"6","author":"Waters V","year":"2020","unstructured":"Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database Syst Rev 2020;6:CD010004-CD010004.32521055","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201404-166OC"},{"key":"e_1_3_3_62_2","first-page":"CD001021","article-title":"Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.","volume":"11","author":"Smith S","year":"2022","unstructured":"Smith S, Rowbotham NJ. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev 2022;11:CD001021-CD001021.36373968","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1103"},{"key":"e_1_3_3_64_2","first-page":"CD002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.","volume":"9","author":"Francis NZ","year":"2022","unstructured":"Francis NZ, Southern KW. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. Cochrane Database Syst Rev 2022;9:CD002204-CD002204.36053129","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2022"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.02.010"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.01.012"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.04.009"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.04.010"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.07.008"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00434-9"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-0858"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219086"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.07.004"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1758734"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0154-2022"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147606"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03380-2020"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201802-0243LE"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0392OC"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202201-0219OC"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.11.006"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.12.012"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202006-614RL"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.05.015"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(88)90063-7"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2015.10.012"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.0740"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.03.010"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.08.017"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207488"},{"key":"e_1_3_3_92_2","first-page":"6708865","article-title":"Global burden of anxiety and depression among cystic fibrosis patient: systematic review and meta-analysis.","volume":"2021","author":"Guta MT","year":"2021","unstructured":"Guta MT, Tekalign T, Awoke N, Fite RO, Dendir G, Lenjebo TL. Global burden of anxiety and depression among cystic fibrosis patient: systematic review and meta-analysis. Int J Chronic Dis 2021;2021:6708865-6708865.34307644","journal-title":"Int J Chronic Dis"},{"key":"e_1_3_3_93_2","unstructured":"Depression anxiety and cystic fibrosis: guide for CF clinicians. Cystic Fibrosis Foundation (https:\/\/www.cff.org\/sites\/default\/files\/2021-10\/Depression-Anxiety-and-Cystic-Fibrosis-Guide-for-CF-Clinicians.pdf)."},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1177\/17534666221144211"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1179208"},{"key":"e_1_3_3_96_2","unstructured":"Canadian clinical consensus guideline for initiation monitoring and discontinuation of CFTR modulator therapies for patients with cystic fibrosis. Cystic Fibrosis Canada July 2021 (https:\/\/www.cysticfibrosis.ca\/uploads\/CFC%20Modulator%20Guidelines.pdf)."},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10010023"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.06.003"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2022.172"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2022.06.004"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.04.008"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMra2216474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T19:08:08Z","timestamp":1752779288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMra2216474"}},"subtitle":[],"editor":[{"given":"Darren B.","family":"Taichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":100,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,11,2]]}},"alternative-id":["10.1056\/NEJMra2216474"],"URL":"https:\/\/doi.org\/10.1056\/nejmra2216474","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]}}}